The Annual Report 2020 is available at the corporate website: https://www.calmark.se/eng/investors/reports-and-presentations

CEO Anna Söderlund comments:
"It is with great pride and humility I look back on the past year; despite the numerous changes in the outside world, Calmark has managed to grow and to accomplish a large number of difficult and complex tasks. 

Undeniably, the most important are the CE marking of our first product, Neo-Bilirubin, and our first incoming orders. This demonstrates not only that we are able to develop products, but also that there is a market demand for them. During the year, a number of distributor agreements have been concluded, in the Nordic countries and the Middle East, and with Via Global Health, active in low- and middle-income countries worldwide."

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.